Clinical trial
An Open-label, Randomized, Multi-center, Parallel-group Clinical Trial Comparing the Efficacy and Safety of Insulin Lispro Biphasic 25 ("Geropharm", Russia) Humalog® Mix 25 ("Lilly France", France) in Type 2 Diabetes Mellitus Patients
NCT04023344 is registered in ClinicalTrials.gov with Geropharm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Randomized, Multi-center, Parallel-group Clinical Trial Comparing the Efficacy and Safety of Insulin Lispro Biphasic 25 ("Geropharm", Russia) Humalog® Mix 25 ("Lilly France", France) in Type 2 Diabetes Mellitus Patients
- Lead sponsor
- Geropharm
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 14, 2018
- Completion date
- April 18, 2019
- Enrollment
- 210 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.